The 12-lead ECG hasn’t changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors should trust the model
As interest in peptide therapy continues to grow, CeliaRx is positioning itself as a trusted destination for personalized, physician-guided peptide care.
In this week’s edition of InnovationRx, we look at breakthroughs from ASCO, Harrison.ai’s U.S. expansion, Clear’s move into healthcare and more.
New York Knicks big man Karl-Anthony Towns, who will play a big role against the San Antonio Spurs in the NBA Finals, talked how he manages his pain and recovery.
After conquering airport security checkpoints, Clear’s billionaire CEO Caryn Seidman Becker wants to use your biometrics to unlock doctors’ appointments, baseball games and the rest of your life.
Whether American healthcare reorganizes around prevention will be a test of the quality of its leadership.
A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer patients
While the most favored nation initiatives have bold aims to lower the cost of drugs, the impact is limited, and in some instances unclear, a case of style over substance.
A physician assistant with no symptoms and a clear colonoscopy was three years from her next screening. A blood test found Stage 3 colon cancer
A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent chemotherapy directly into cancer cells.